Your browser doesn't support javascript.
loading
Efficacy of rituximab in thymoma associated minimal change disease: case report.
El Ouafi, Zhour; Mugnier, Clovis; Jeannet, Robin; Danthu, Clément; Duval, Marion; Belle Mbou, Valère; Touré, Fatouma.
  • El Ouafi Z; CHU Limoges, Division of Nephrology, Limoges, France.
  • Mugnier C; CHU Limoges, Division of Nephrology, Limoges, France.
  • Jeannet R; CHU Limoges, Division of Immunology, Limoges, France.
  • Danthu C; CNRS 7276 - Inserm U1262, CRIBL, University of Limoges, Limoges, France.
  • Duval M; CHU Limoges, Division of Nephrology, Limoges, France.
  • Belle Mbou V; CHU Limoges, Division of Nephrology, Limoges, France.
  • Touré F; CHU Limoges, Division of Anatomopathology, Limoges, France.
BMC Nephrol ; 22(1): 303, 2021 09 07.
Article en En | MEDLINE | ID: mdl-34493204

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Timoma / Neoplasias del Timo / Rituximab / Factores Inmunológicos / Nefrosis Lipoidea Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Timoma / Neoplasias del Timo / Rituximab / Factores Inmunológicos / Nefrosis Lipoidea Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article